S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Biden To Unleash "Choke Point" Operation On America? (Ad)
Closing prices for crude oil, gold and other commodities
KB Home Strong Results Lift Prices
Biden To Unleash "Choke Point" Operation On America? (Ad)
Trump arrested? Putin jailed? Fake AI images spread online
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Biden To Unleash "Choke Point" Operation On America? (Ad)
Lawsuit: Slurs, coercion at BBQ chain with racist history
Coinbase tumbles after SEC warns of securities violations
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Biden To Unleash "Choke Point" Operation On America? (Ad)
Closing prices for crude oil, gold and other commodities
KB Home Strong Results Lift Prices
Biden To Unleash "Choke Point" Operation On America? (Ad)
Trump arrested? Putin jailed? Fake AI images spread online
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Biden To Unleash "Choke Point" Operation On America? (Ad)
Lawsuit: Slurs, coercion at BBQ chain with racist history
Coinbase tumbles after SEC warns of securities violations
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Biden To Unleash "Choke Point" Operation On America? (Ad)
Closing prices for crude oil, gold and other commodities
KB Home Strong Results Lift Prices
Biden To Unleash "Choke Point" Operation On America? (Ad)
Trump arrested? Putin jailed? Fake AI images spread online
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Biden To Unleash "Choke Point" Operation On America? (Ad)
Lawsuit: Slurs, coercion at BBQ chain with racist history
Coinbase tumbles after SEC warns of securities violations
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Biden To Unleash "Choke Point" Operation On America? (Ad)
Closing prices for crude oil, gold and other commodities
KB Home Strong Results Lift Prices
Biden To Unleash "Choke Point" Operation On America? (Ad)
Trump arrested? Putin jailed? Fake AI images spread online
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Biden To Unleash "Choke Point" Operation On America? (Ad)
Lawsuit: Slurs, coercion at BBQ chain with racist history
Coinbase tumbles after SEC warns of securities violations
NASDAQ:ADXS

Ayala Pharmaceuticals - ADXS Competitors

$1.50
+0.14 (+10.29%)
(As of 03/23/2023 09:00 PM ET)
Add
Compare
Today's Range
$1.30
$1.50
50-Day Range
N/A
52-Week Range
$1.00
$10.71
Volume
3,300 shs
Average Volume
7,804 shs
Market Capitalization
$2.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ADXS vs. ATNM, AMPE, AWH, PGEN, and DYN

Should you be buying Ayala Pharmaceuticals stock or one of its competitors? The main competitors of Ayala Pharmaceuticals include Actinium Pharmaceuticals (ATNM), Ampio Pharmaceuticals (AMPE), Aspira Women's Health (AWH), Precigen (PGEN), and Dyne Therapeutics (DYN).

Ayala Pharmaceuticals vs.

Ayala Pharmaceuticals (NASDAQ:ADXS) and Actinium Pharmaceuticals (NYSE:ATNM) are both health technology companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, community ranking, valuation, analyst recommendations, media sentiment and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Ayala Pharmaceuticals N/A N/A N/A
Actinium Pharmaceuticals N/A N/A N/A

Ayala Pharmaceuticals and Actinium Pharmaceuticals both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Ayala PharmaceuticalsOutperform Votes
No Votes
Underperform Votes
1
100.00%
Actinium PharmaceuticalsOutperform Votes
No Votes
Underperform Votes
1
100.00%

In the previous week, Ayala Pharmaceuticals' average media sentiment score of 0.00 equaled Actinium Pharmaceuticals' average media sentiment score.

Company Overall Sentiment
Ayala Pharmaceuticals Neutral
Actinium Pharmaceuticals Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ayala PharmaceuticalsN/AN/AN/AN/AN/A
Actinium PharmaceuticalsN/AN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ayala Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Actinium Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Ayala Pharmaceuticals and Actinium Pharmaceuticals tied by winning 0 of the 0 factors compared between the two stocks.

ADXS vs. The Competition

MetricAyala PharmaceuticalsPharmaceuticals: Major IndustryHealth Tech SectorNASDAQ Exchange
Market CapN/A$43.52B$26.30B$5.89B
Dividend YieldN/A3.27%3.27%4.41%
P/E RatioN/A22.8415.8812.46
Price / SalesN/A168.55371.6766.05
Price / CashN/AN/AN/A102.99
Price / BookN/AN/AN/A4.95
Net IncomeN/A-$4.07MN/A$190.85M
7 Day PerformanceN/A1.59%-0.98%0.21%
1 Month PerformanceN/A-7.06%-10.24%-6.24%
1 Year PerformanceN/A-27.38%N/A-19.14%

Ayala Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATNM
Actinium Pharmaceuticals
0 of 5 stars
$9.20
+0.3%
N/AN/A$0.00N/A0.00N/AUpcoming Earnings
Analyst Downgrade
AMPE
Ampio Pharmaceuticals
0 of 5 stars
$0.23
-10.6%
N/AN/A$0.00N/A0.00N/AUpcoming Earnings
Analyst Report
AWH
Aspira Women's Health
0 of 5 stars
$0.42
-16.0%
N/AN/A$0.00N/A0.00N/ANews Coverage
PGEN
Precigen
0 of 5 stars
$0.94
-6.9%
N/AN/A$236.36M$26.91M7.81N/A
DYN
Dyne Therapeutics
0 of 5 stars
$11.18
-2.6%
N/AN/A$629.86MN/A-3.45N/A
This page (NASDAQ:ADXS) was last updated on 3/24/2023 by MarketBeat.com Staff